Barron’s spoke with Dave Moore, executive vice president of U.S. operations, about Wegovy as a pill, rather than an injection.
A closely watched pill from Novo Nordisk just scored an approval for slashing cardiovascular risks, while Mark Cuban gives Trump credit on drug prices.
Novo Nordisk faces a challenge in tapping into the U.S. mass market for weight-loss drugs. With new board leadership, the ...
Novo Nordisk today announced new data on the investigational oral semaglutide 25 mg will be among 23 abstracts to be ...
Wall Street analysts can't agree on Novo Nordisk ( NVO -1.29%), with Morgan Stanley recently cutting its rating to ...
Novo Nordisk, which lobbied to win Medicaid reimbursement for its obesity drug Wegovy, is fighting to keep that coverage as ...
A new era of weight-loss treatment could soon trade needles for pills. Drugmakers behind GLP-1 injections like Wegovy and Zepbound are racing to launch once-daily oral versions that may help people ...
LONDON (Reuters) -Boardroom drama at Wegovy-maker Novo Nordisk has laid bare the company's biggest challenge: how to better ...
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...
18d
Sam's Club, Costco Selling Discounted Weight Loss Drugs Without Insurance. How Much Will They Cost?
Popular weight loss drugs are now available at a discount for Sam's Club and Costco shoppers without insurance. The deals ...
The pill could offer an alternative to weekly injections of GLP-1 drugs WEDNESDAY, Sept. 24, 2025 (HealthDay News) — A pill form of the blockbuster weight-loss drug Ozempic can help overweight or ...
The age of the GLP-1 drug has reached yet another milestone, with the US Food and Drug Administration green-lighting Novo Nordisk's once-daily oral semaglutide pill to treat people at high risk of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback